The year in cardiology: coronary interventions

  • Andreas Baumbach Department of Cardiology Barts Heart Centre Barts Health NHS Trust Centre for Cardiovascular Medicine and Devices William Harvey Research Institute Queen Mary University of London
  • Christos Bourantas Department of Cardiology Barts Heart Centre Barts Health NHS Trust Centre for Cardiovascular Medicine and Devices William Harvey Research Institute Queen Mary University of London Institute of Cardiovascular Sciences, University College London
  • Patrick Serruys International Centre for Circulatory Health Imperial College London The Lambe Institute for Translational Medicine and Curam Saolta University Healthcare Group National University of Ireland Galway
  • William Wijns The Lambe Institute for Translational Medicine and Curam Saolta University Healthcare Group National University of Ireland Galway

Abstract

Percutaneous coronary intervention (PCI) research focuses on the optimisation of treatment strategies, the development of novel equipment and pharmacotherapies for improved results, and on risk stratification and identification of high-risk patients that will benefit from emerging therapies targeting atherosclerotic evolution. Over the last year, important clinical studies have been reported that examined the efficacy of different treatment strategies and stent platforms in patients with obstructive coronary artery disease (CAD), and guidelines have been published to provide recommendations about the management of these patients. The aim of this article is to summarise the findings of the pivotal studies published in 2019 and to discuss their impact on clinical practice.

Published
2020-06-26
Section
Articles